TransformativeMed announced that it has closed a $5.8 million Series A financing deal. The funds will be used to accelerate sales and marketing efforts to support expansion of the CORES Value Suite solution (CORES).
According to TransformativeMed leadership, CORES is designed to address complex conditions like diabetes to provide relevant electronic health record (EHR) data to clinicians real-time through text and smart messaging. TransformativeMed solutions are used by tens of thousands of clinicians in more than 130 hospitals and health systems.
Founded in 2011, privately-held TransformativeMed re-engineers EHR workflows with directly embedded, clinician-friendly solutions. CORES curates EHR-based patient information and presents it in the unique way each specialty requires.
This was reported by TransformativeMed on May 7, 2019.